Nitrite analysis in pharmaceuticals: monitoring a precursor to nitrosamine
Nitrosamines are carcinogenic, even at trace levels. As a result, the FDA has issued guidance regarding monitoring nitrosamine impurities in drugs for human consumption [1].
General Chapter Preconcentration Technique Matrix Elimination Application Notes Ion Chromatography Sample Preparation
Source: news-medical.net